Treatment of Bulimia with Monoamine Oxidase Inhibitors
The authors describe the cases of six patients with bulimia who also had symptoms of atypical depression and who responded dramatically to treatment with monoamine oxidase inhibitors.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.